Using a hollow microstructured transdermal system to deliver vaccine directly to the dermis.
Dave Cunningham
Advertisement
Dave Cunningham is director, corporate development at Goodwin Biotechnology.
Articles by Dave Cunningham
Advertisement
Latest Updated Articles
Optimizing a Unique Cancer Vaccine for Intradermal DeliveryPublished: September 15th 2017 | Updated:
Advertisement
Advertisement
Trending on BioPharm International
1
2025 PharmSci 360 to Showcase Essential AI Integration and Emerging Technologies
2
Top 10 Questions from CPHI Frankfurt: Building Pharma Resilience a Common Theme
3
Meeting Global Demand and Delivering Faster, More Reliable Service
4
Pharma Tariff FAQ: Costs, Supply Chains, Policy for 2025
5
